Metastatic Breast Cancer Shifts Toward Chronic Care Model As Survival Rates Rise
Managing long-term metastatic breast cancer treatment requires balancing continuous systemic therapies with monitoring cumulative side effects like neuropathy and fatigue. For decades, a diagnosis of metastatic breast cancer carried a grim prognosis, with survival often measured in months or a few short years. By 2025, that landscape has shifted. Improved surveillance, targeted drugs, and a … Read more